▶ 調査レポート

骨&関節健康用サプリメントの世界市場(2023~2028):ビタミンD、ビタミンK、カルシウム、コラーゲン、その他

• 英文タイトル:Bone and Joint Health Supplements Market - Growth, Trends, and Forecasts (2023 - 2028)

Bone and Joint Health Supplements Market - Growth, Trends, and Forecasts (2023 - 2028)「骨&関節健康用サプリメントの世界市場(2023~2028):ビタミンD、ビタミンK、カルシウム、コラーゲン、その他」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2304G241
• 出版社/出版日:Mordor Intelligence / 2023年2月
• レポート形態:英文、PDF、110ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:食品
• 販売価格(消費税別)
  Single User¥703,000 (USD4,750)▷ お問い合わせ
  Corporate License¥1,295,000 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
モルドールインテリジェンス社の本調査資料では、世界の骨&関節健康用サプリメント市場規模が、今後5年の間にCAGR6.6%で拡大すると展望しています。本資料は、骨&関節健康用サプリメントの世界市場について調査を行い、市場の現状や動向をまとめています。イントロダクション、調査手法、エグゼクティブサマリー、市場動向、ビタミンD、ビタミンK、カルシウム、コラーゲン、その他、地域別(アメリカ、カナダ、メキシコ、スペイン、イギリス、フランス、ドイツ、ロシア、イタリア、中国、日本、オーストラリア、インド、ブラジル、アルゼンチン、南アフリカ、UAE)分析、競争状況、市場機会・将来の動向など、以下の項目を掲載しています。また、主要参入企業として、JSH international、LLC 、Pfizer Inc.、Bayer AG、Reckitt Benckiser Group plc、Xtend-Life Group Limited、Vitascience Foods LTDA、The Procter & Gamble Company、Nature's Bounty、Inc.、Amway Corp.、BioScience Nutrition、BIOSTIME NUTRITION (Swisse Wellness PTY LTD)などの情報を含んでいます。

・イントロダクション
・調査手法
・エグゼクティブサマリー
・市場動向
・世界の骨&関節健康用サプリメント市場規模:種類別
- ビタミンDの市場規模
- ビタミンKの市場規模
- カルシウムの市場規模
- コラーゲンの市場規模
- その他の市場規模
・世界の骨&関節健康用サプリメント市場規模:流通チャネル別
- スーパーマーケット/ハイパーマーケットチャネルの市場規模
- 薬局チャネルの市場規模
- 医療チャネルの市場規模
- コンビニエンスストアチャネルの市場規模
- その他の市場規模
・世界の骨&関節健康用サプリメント市場規模:地域別
- 北米の骨&関節健康用サプリメント市場規模
アメリカの骨&関節健康用サプリメント市場規模
カナダの骨&関節健康用サプリメント市場規模
メキシコの骨&関節健康用サプリメント市場規模

- ヨーロッパの骨&関節健康用サプリメント市場規模
イギリスの骨&関節健康用サプリメント市場規模
フランスの骨&関節健康用サプリメント市場規模
イタリアの骨&関節健康用サプリメント市場規模

- アジア太平洋の骨&関節健康用サプリメント市場規模
中国の骨&関節健康用サプリメント市場規模
インドの骨&関節健康用サプリメント市場規模
日本の骨&関節健康用サプリメント市場規模

- 南米/中東の骨&関節健康用サプリメント市場規模
ブラジルの骨&関節健康用サプリメント市場規模
アルゼンチンの骨&関節健康用サプリメント市場規模
南アフリカの骨&関節健康用サプリメント市場規模

- その他地域の骨&関節健康用サプリメント市場規模
・競争状況
・市場機会・将来の動向

The Global Bone and Joint Health Supplements Market are projected to grow at a CAGR of 6.6% over the next five years.

Consumers’ desire for self-care is fueling the growth of bone and joint supplements. Customers were stepping out more during the lockdown and hunting for these things. Therefore the category grew. As more people stay home, they are increasingly concerned about their health. The aging population across countries such as Japan and Germany, among others, is among the critical demographics expected to propel the demand further. The aging population is aspiring for ease of movement and joint comfort, which has substantially pushed the market studied. This trend is certainly continuing, with the rise of more specific, cleaner, and free-from-label bone and joint health supplements, as an indicator of the popularity and acceptance of natural products. The senior population of conscious of composition ingredients’ also seeking aged plant-based herbal ingredients, such as turmeric, is, and tart cherry, in contrast to animal-derived ingredients, such as glucosamine and chondroitin, driving the demand for herbal/natural bone and joint health supplements. Women are more prone to calcium deficiency, which results in brittle and weak bones and joints. Calcium supplements Boswellia can potentially reduce the adverse effects of calcium deficiency in women, like hypertensive conditions during pregnancy, which are concurrent with a vast number of maternal deaths and considerable risk of premhaveinfant birth infants. Thus, it is mainly recommended by medical practitioners for women to consume calcium supplements after menopause and during pregnancy. WHO and the Food and Agriculture Organization of the United Nations (FAO) have recommended a calcium intake of 1200 mg/day for pregnant ladies. Consequently, supplement consumption serves the growth of the calcium supplement market.

Over the past years, the sports and fitness industry has witnessed significant participation from the millennials addressing the need for active lifestyles regularly. This segment of demographics is anticipated to scale the demand for bone and joint supplements since most of the prescribed supplements result from undertaking steps toward a preventive measure.

Bone & Joint Health Supplements Market Trends

Significant Volume of Demand Solely from the Ageing Population

The market studied primarily thrives on the aging population highly susceptible to bone injuries and fractures—the best target audience for worldwide bone and joint health supplement manufacturers. Arthritis is one of the most common autoimmune diseases faced by the global population. The rising number of patients with osteoporosis and rheumatoid arthritis is leading manufacturers to produce collagen-based candies, supplements, and drinks, which, when orally consumed, deliver good results. The aging process naturally makes consumers aware of their bone health. Maintaining a healthy lifestyle and preventing age-related bone diseases, particularly at an older age, is making consumers pay premium prices for these supplements, as they impart health benefits, targeting treatment of a specific segment of the human body.

Furthermore, the aging population is aspiring for ease of movement and joint comfort, which has substantially pushed the market studied. The World Health Organization (WHO) estimated that almost 22 million individuals in Europe and 14 million in the United States alone would have osteoporosis. According to the National Library of Medicine, in 2021, it was observed that more than 1033 million people had osteoporosis. These alarming figures have given significant momentum to the market studied.

North America Holds the Largest Market Share

Healthcare expenditure in North America is rising every year, with advanced technology, advanced pharmacy distribution channel, better medical facilities, and a rise in the number of insured people. According to the Bureau of Labor Statistics, In the United States, the average value of health insurance in 2021 amounted to USD 3,703.61 per consumer unit, and the average expenditure on non-prescribed vitamins which included bone and joint health supplements like vitamin D and vitamin K in the United States has increased over the past few years. These factors are driving the bone and joint health supplements market in the country.

Moreover, calcium is one of the most in-demand supplements among women in North America, with a growing aged population, arthritis cases, and other bone and joint diseases. The huge mass of the aged population and youth population has been seeking supplements including bone and joint health supplements either to cure/ maintain bone and joint health have been driving the market. According to World Bank data, in 2021, 17.04 percent of the population was over 65 years old, while 64.72 percent of people were between the ages of 15 and 64. The vast demand for dietary supplements in general, including bone and joint health supplements, makes North America a frontrunner in the bone and joint health supplements market.

Besides this, high consumption of processed food that is low in nutrition necessitates the use of supplements to prevent bone and joint disorders in old age. This impels the growth of the bone and joint health supplements market in the region.

Bone & Joint Health Supplements Market Competitor Analysis

The bone and joint health supplements market is expected to be highly competitive in the future, owing to the increasing demand for these supplements across various age groups to prevent early bone disorders. North America dominates the global bone and joint health supplements market, followed by Europe. The major players in this segment are Amway Corp., BIOSTIME NUTRITION (Swisse Wellness PTY LTD), Nature’s Bounty, Inc., The Procter & Gamble Company, and Reckitt Benckiser Group Plc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
レポート目次

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Porter’s Five Forces Analysis
4.3.1 Threat of New Entrants
4.3.2 Bargaining Power of Buyers/Consumers
4.3.3 Bargaining Power of Suppliers
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Vitamin D
5.1.2 Vitamin K
5.1.3 Calcium
5.1.4 Collagen
5.1.5 Glucosamine-Chondroitin
5.1.6 Omega-3 Fatty Acid
5.1.7 Other Types
5.2 By Distribution Channel
5.2.1 Supermarkets/Hypermarkets
5.2.2 Pharmacies
5.2.3 Health Stores
5.2.4 Convenience Stores
5.2.5 Online Stores
5.2.6 Other Distribution Channels
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.1.4 Rest of North America
5.3.2 Europe
5.3.2.1 Spain
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Germany
5.3.2.5 Russia
5.3.2.6 Italy
5.3.2.7 Rest of Europe
5.3.3 Asia Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 Australia
5.3.3.4 India
5.3.3.5 Rest of Asia-Pacific
5.3.4 South America
5.3.4.1 Brazil
5.3.4.2 Argentina
5.3.4.3 Rest of South America
5.3.5 Middle East
5.3.5.1 South Africa
5.3.5.2 United Arab Emirates
5.3.5.3 Rest of Middle East

6 COMPETITIVE LANDSCAPE
6.1 Most Adopted Strategies
6.2 Market Share Analysis
6.3 Company Profiles
6.3.1 JSH international, LLC
6.3.2 Pfizer Inc.
6.3.3 Bayer AG
6.3.4 Reckitt Benckiser Group plc
6.3.5 Xtend-Life Group Limited
6.3.6 Vitascience Foods LTDA
6.3.7 The Procter & Gamble Company
6.3.8 Nature’s Bounty, Inc.
6.3.9 Amway Corp.
6.3.10 BioScience Nutrition
6.3.11 BIOSTIME NUTRITION (Swisse Wellness PTY LTD)

7 MARKET OPPORTUNITIES AND FUTURE TRENDS